Global Intravenous Equipment Market to Reach $5.9 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Intravenous Equipment markets. The global intravenous equipment market is projected to reach $5.9 billion by the year 2015, led by the growing demand for smart infusion pumps. Rising concerns pertaining to patient/worker safety, adverse drug reactions, and accidental needlestick injuries are enhancing the demand for smart infusion systems.

Intravenous Equipment: A Global Strategic Business Report

Intravenous equipment enables the delivery of medication directly into the patient’s circulatory system. Safety of patient and caregiver owing to increased awareness levels among consumers as well as physician community, rising incidences of accidental needlestick injuries, and growing number of medical error related deaths have emerged as major concerns for the international healthcare community. The need for addressing such issues is contributing towards the growing demand for advanced equipment with higher safety features, which are capable of reducing intravenous medication errors. Modern variants of intravenous devices are highly specialized gadgets that allow electronic measurement of medication, and enable administration of concentrated doses of medication at precise rates. From vascular or arterial line catheters designed to read blood oxygen levels directly from the patient’s arm, to epidural catheters that administer morphine drugs straight into the spinal cord to ease pain, the changing dynamics of intravenous equipment are centered on improving the patient’s quality of life.

The medical device industry has been significantly shielded from the short-term impact of fluctuations in the global economy, largely due to the ‘essential’ characteristic of the healthcare industry that is not dependent on the level of consumers’ discretionary spending. Further, rapidly expanding global population, rising proportion of the elderly, and increasing life expectancies are contributing to increased demand for healthcare products and services. However, the decline in elective, orthopedic, and cosmetic procedures has affected the profitability of hospitals and device manufacturers.

The United States, Japan, and Europe account for more than 85% of global intravenous equipment sales, as stated by the new market research report on intravenous equipment. Growing dependence on intravenous drug therapy and the need for accurate administration of intravenous fluids are contributing to strong growth in the global intravenous equipment market. Though intravenous equipment is designed for both general care and critical care applications, majority of these systems are used in general care applications. Level of control offered to patients and medical professionals determines the popularity of an intravenous system. Other factors affecting the market include programmability, weight, size, cost, service, number of delivery channels offered, and mechanism of infusion.

Infusion Pumps and Sets represents the largest and fastest growing segment in the intravenous equipment market. Technological advancements have led to the development of smart infusion systems, which have dramatically transformed the delivery of intravenous therapy. Smart infusion systems are highly specialized gadgets that allow electronic measurement of medication, and enable administration of controlled doses of medication at precise rates. Modern equipment such as electronic and disposable infusion pumps are more intelligent, smarter, and effective. The devices incorporate high-end features such as optimum patient control, infection control, and remote programming.

Players in the global intravenous equipment market compete on the basis of technology, product features and clinical performance. Ease of use, clarity of user interface, size, capabilities, cost, and service requirements represent other competitive factors. Major players profiled in the report include B. Braun Melsungen AG, Baxter International, Becton, Dickinson and Company, C.R. Bard Inc., CareFusion Corporation, Covidien Ltd, Fresenius Kabi AG, Hospira Inc., Medtronic Inc., Moog Inc., St. Jude Medical Inc., and Teleflex Medical.

The report titled “Intravenous Equipment: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a review of market trends, product introductions/innovations, and recent industry activity. The study analyzes market data and analytics in terms of value sales for regions including the United States, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Intravenous_Equipment_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press(at)StrategyR(dot)com
Web Site http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website

Media